Kewaunee Scientific (KEQU) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for August 28, 2024, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by August 27, 2024.
Voting matters and shareholder proposals
Election of Keith M. Gehl as Class II Director is up for shareholder vote.
Ratification of Forvis Mazars, LLP as independent auditors for fiscal year 2025 is proposed.
Advisory vote on executive compensation for named executives is included.
Proxies may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals presented, including director election and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Kewaunee Scientific
- Sales rose but net income fell amid higher costs and Nu Aire integration expenses.KEQU
Q3 202613 Mar 2026 - Sales surged 46.8% to $70.1M, but net earnings dropped 18.7% amid integration costs.KEQU
Q2 202612 Dec 2025 - Q1 FY2026 sales and earnings surged, fueled by the Nu Aire acquisition and a strong backlog.KEQU
Q1 202610 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and governance policies.KEQU
Proxy Filing2 Dec 2025 - Annual meeting to vote on director, auditor, and executive pay, with a focus on governance and performance.KEQU
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditors, and executive pay, with board support for all.KEQU
Proxy Filing2 Dec 2025 - Adjusted earnings and sales surged, fueled by Nu Aire integration and strong domestic growth.KEQU
Q4 202526 Jun 2025 - Gross margin and net earnings rose as Nu Aire was acquired and backlog reached a record high.KEQU
Q2 202513 Jun 2025 - Backlog and quoting activity remain strong despite a slight year-over-year earnings decline.KEQU
Q1 202513 Jun 2025